Alfredo Grossi (Freddie)

Alfredo "Freddie" Grossi has over 22 years of experience in the pharmaceutical industry. Alfredo "Freddie" is currently the Vice President of Technical Operations at Akebia Therapeutics, a position they have held since October 2022. Prior to this, they served as the Senior Director of Strategy and Analytical, Senior Director of CMC Development and Commercial Strategy, and Senior Director of Technical Operations at Akebia Therapeutics.

Before joining Akebia Therapeutics, Grossi was the Sr. Director of Pharmaceutical Development and CMC at Tiburio Therapeutics from April 2019 to April 2020. Alfredo "Freddie" also served as the Senior Director of Pharmaceutical Development at scPharmaceuticals from June 2017 to February 2019.

Grossi's previous experience includes roles as the Director of CMC at Stealth BioTherapeutics from August 2014 to May 2017, Associate Director of CMC Technical Development at Infinity Pharmaceuticals from August 2013 to August 2014, and various managerial and scientific positions at Ironwood Pharmaceuticals from July 2007 to August 2013.

Alfredo "Freddie" started their career as a Product Development Technician at Sovereign Pharmaceuticals in June 1999 and worked their way up to become the Product Development Manager before leaving in May 2003.

Grossi holds a wealth of experience in technical operations, strategy, analytical, CMC development, and pharmaceutical development.

Alfredo "Freddie" Grossi attended Boston College from 1993 to 1997, where they earned their Bachelor of Science degree in Biology. In addition to their degree, they have obtained certifications in Lean Six Sigma and Six Sigma Green Belt from Villanova University. The exact dates of when they obtained these certifications are not provided.